Approval · Notice of Compliance 15986 · 2014
LEVAQUIN: Notice of Compliance 15986
Issued August 20, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15986
- Date
- August 20, 2014
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of references to the discontniued iv formulation from pm
- Therapeutic class
- Antibacterial agent
Products in this notice
Medicinal ingredients
- LEVOFLOXACIN 250 MG per TAB
- LEVOFLOXACIN 500 MG per TAB
- LEVOFLOXACIN 750 MG per TAB